Document Detail


Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.
MedLine Citation:
PMID:  21951517     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PROBLEM: Maternal tolerance of the fetus is essential for viviparity, yet anti-fetal rejection occurs in several pregnancy complications. Chronic chorioamnionitis is a feature of anti-fetal cellular rejection. There is a robust association between chronic chorioamnionitis and maternal seropositivity for anti-human leukocyte antigen (HLA) panel-reactive antibodies (PRA) at the time of delivery. This longitudinal study was performed to assess maternal HLA PRA status in early gestation and the temporal evolution of maternal HLA PRA in the context of chronic chorioamnionitis and, thereby, to determine whether HLA PRA during the course of pregnancy is useful for the detection of anti-fetal rejection.
METHOD OF STUDY: Maternal sera obtained before 16 weeks of gestation and at delivery were analyzed for HLA PRA in cases with (N = 100) and without (N = 150) chronic chorioamnionitis.
RESULTS: IgG (but not IgM) HLA class I and II PRA positivity at delivery was higher in cases with chronic chorioamnionitis than in those without chronic chorioamnionitis. IgG HLA class I PRA positivity before 16 weeks of gestation was higher in cases with chronic chorioamnionitis than in those without (30.3 versus 13.3%; P = 0.001). Positive conversion (negative HLA PRA before 16 weeks of gestation but positive at delivery) of IgG HLA class I and II PRA was significantly associated with chronic chorioamnionitis. Fetal HLA class I antigen-specific antibodies were confirmed in 12 of 16 mothers tested who were sensitized to HLA class I antigens before 16 weeks of gestation.
CONCLUSION: Positive maternal HLA PRA before 16 weeks of gestation and the temporal evolution of maternal HLA PRA are associated with the presence of chronic chorioamnionitis at the time of delivery. Maternal IgG HLA PRA has the potential to be a monitoring tool of anti-fetal rejection. Furthermore, the findings herein indicate that subsets of fetuses are exposed to alloimmune HLA antibodies for months, especially in cases with chronic chorioamnionitis.
Authors:
JoonHo Lee; Roberto Romero; Yi Xu; Jung-Sun Kim; Ji Young Park; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sonia S Hassan; Chong Jai Kim
Related Documents :
15852177 - Feto-amniotic shunting -- experience of six centres.
19007 - Activities of some peptidases and glycolytic enzymes in cells of the amniotic fluid. i....
6984387 - Amniotic fluid levels of 17 alpha-hydroxyprogesterone during human pregnancy: pre-natal...
3738367 - Hydroxyproline and creatinine levels in normal amniotic fluid.
9409857 - Differential increases in afp, hcg, and ue3 in twin pregnancies: impact on attempts to ...
14757997 - Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural     Date:  2011-09-27
Journal Detail:
Title:  American journal of reproductive immunology (New York, N.Y. : 1989)     Volume:  66     ISSN:  1600-0897     ISO Abbreviation:  Am. J. Reprod. Immunol.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-10     Completed Date:  2012-03-19     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  8912860     Medline TA:  Am J Reprod Immunol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  510-26     Citation Subset:  IM    
Copyright Information:
© 2011 John Wiley & Sons A/S.
Affiliation:
Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, MD, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Autoantibodies / blood
Chorioamnionitis / blood,  epidemiology,  immunology*,  pathology
Chronic Disease
Female
Graft Rejection / epidemiology*,  immunology
Histocompatibility Antigens Class I / immunology*
Histocompatibility Antigens Class II / immunology*
Humans
Immunoglobulin G / blood*
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases / epidemiology*,  immunology
Male
Middle Aged
Pregnancy
Premature Birth / etiology,  immunology*
Young Adult
Grant Support
ID/Acronym/Agency:
ZIA HD002400-19/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Autoantibodies; 0/Histocompatibility Antigens Class I; 0/Histocompatibility Antigens Class II; 0/Immunoglobulin G
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting erectile dysfunction following surgical correction of Peyronie's disease without inflatab...
Next Document:  Estimating the budget impact of orphan medicines in Europe: 2010 - 2020.